If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...

AstraZeneca PLC (AZN) stock saw a modest uptick, ending the day at $67.01 which represents a slight increase of $0.43 or 0.65% from the prior close of $66.58. The stock opened at $67.19 and touched a ...

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Fort Myers-based cancer lab NeoGenomics is getting a new CEO. Tony Zook, an independent board member, will assume the role.

Shares of NeoGenomics, Inc. (NASDAQ: NEO) are, after the company announced that CEO Chris Smith will retire effective April 1 ...

MI-HQ will anchor Dan Gilbert’s Bedrock development at the former “fail jail” site on Gratiot Avenue in downtown Detroit with ...

U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.